GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Shenqi Pharmaceutical Investment Management Co Ltd (SHSE:900904) » Definitions » Gross Profit

Shanghai Shenqi Pharmaceutical Investment Management Co (SHSE:900904) Gross Profit : $146.5 Mil (TTM As of Jun. 2024)


View and export this data going back to 1992. Start your Free Trial

What is Shanghai Shenqi Pharmaceutical Investment Management Co Gross Profit?

Shanghai Shenqi Pharmaceutical Investment Management Co's gross profit for the three months ended in Jun. 2024 was $33.6 Mil. Shanghai Shenqi Pharmaceutical Investment Management Co's gross profit for the trailing twelve months (TTM) ended in Jun. 2024 was $146.5 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Shanghai Shenqi Pharmaceutical Investment Management Co's gross profit for the three months ended in Jun. 2024 was $33.6 Mil. Shanghai Shenqi Pharmaceutical Investment Management Co's Revenue for the three months ended in Jun. 2024 was $73.9 Mil. Therefore, Shanghai Shenqi Pharmaceutical Investment Management Co's Gross Margin % for the quarter that ended in Jun. 2024 was 45.46%.

Shanghai Shenqi Pharmaceutical Investment Management Co had a gross margin of 45.46% for the quarter that ended in Jun. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Shanghai Shenqi Pharmaceutical Investment Management Co was 78.70%. The lowest was 47.11%. And the median was 60.60%.

Warning Sign:

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd gross margin has been in long-term decline. The average rate of decline per year is -4.3%.


Shanghai Shenqi Pharmaceutical Investment Management Co Gross Profit Historical Data

The historical data trend for Shanghai Shenqi Pharmaceutical Investment Management Co's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Shenqi Pharmaceutical Investment Management Co Gross Profit Chart

Shanghai Shenqi Pharmaceutical Investment Management Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 173.62 165.73 217.66 181.26 163.71

Shanghai Shenqi Pharmaceutical Investment Management Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.28 34.03 39.69 39.24 33.58

Competitive Comparison of Shanghai Shenqi Pharmaceutical Investment Management Co's Gross Profit

For the Drug Manufacturers - General subindustry, Shanghai Shenqi Pharmaceutical Investment Management Co's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Shenqi Pharmaceutical Investment Management Co's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Shenqi Pharmaceutical Investment Management Co's Gross Profit distribution charts can be found below:

* The bar in red indicates where Shanghai Shenqi Pharmaceutical Investment Management Co's Gross Profit falls into.



Shanghai Shenqi Pharmaceutical Investment Management Co Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Shanghai Shenqi Pharmaceutical Investment Management Co's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=327.854 - 164.149
=163.7

Shanghai Shenqi Pharmaceutical Investment Management Co's Gross Profit for the quarter that ended in Jun. 2024 is calculated as

Gross Profit (Q: Jun. 2024 )=Revenue - Cost of Goods Sold
=73.861 - 40.283
=33.6

Gross Profit for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $146.5 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Shanghai Shenqi Pharmaceutical Investment Management Co's Gross Margin % for the quarter that ended in Jun. 2024 is calculated as

Gross Margin % (Q: Jun. 2024 )=Gross Profit (Q: Jun. 2024 ) / Revenue (Q: Jun. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=33.6 / 73.861
=45.46 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Shanghai Shenqi Pharmaceutical Investment Management Co  (SHSE:900904) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Shanghai Shenqi Pharmaceutical Investment Management Co had a gross margin of 45.46% for the quarter that ended in Jun. 2024 => Durable competitive advantage


Shanghai Shenqi Pharmaceutical Investment Management Co Gross Profit Related Terms

Thank you for viewing the detailed overview of Shanghai Shenqi Pharmaceutical Investment Management Co's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Shenqi Pharmaceutical Investment Management Co Business Description

Traded in Other Exchanges
Address
128 Weihai Road, Room 613, Changfa Building, Shanghai, CHN, 200003
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd is mainly engaged in pharmaceutical production and distribution in China.

Shanghai Shenqi Pharmaceutical Investment Management Co Headlines

No Headlines